Women´s Health Diagnostics Market Report by Type, Application, End User, and Region 2024-2032
부인과 건강검진 세계 시장 규모는 2023년 292억 달러에 달했습니다. IMARC 그룹은 2032년 526억 달러에 달할 것으로 예상하며, 2024-2032년간 6.6%의 연평균 성장률(CAGR)을 나타낼 것으로 예측했습니다.
부인과 검진은 여성 환자의 다양한 생물학적, 심리사회적 상태를 진단하는 데 도움이 됩니다. 성 및 질 문제, 임신 합병증에 대처하고 골다공증, 폐경, 유방암, 자궁경부암 등 위협적인 질환을 관리할 수 있도록 돕습니다. 생검, 초음파 검사, 화학요법, 자기공명영상(MRI) 등 일련의 첨단 임상 검사, 도구 및 기술을 활용하고 있습니다. 현재 일부 의료 진단센터는 여성에게 영향을 미치는 희귀질환 및 상태의 진단과 관리를 강화하기 위해 광범위한 임상 검사 솔루션을 제공합니다.
부인과 건강검진 시장 동향 :
여성의 전반적인 웰빙에 영향을 미치는 건강 문제의 유병률 증가는 시장에 긍정적인 영향을 미치는 주요 요인 중 하나입니다. 또한, 건강에 대한 인식이 높아지고 조기 진단의 이점에 대한 인식이 높아지면서 전 세계적으로 현장 진료(POC) 부인과 검진에 대한 수요가 증가하고 있습니다. 이와는 별도로, 스트레스가 많은 생활 방식과 알코올 및 약물 섭취 증가로 인한 불임률 증가는 임신 합병증에 대처하고 건강한 삶을 보장하기 위해 부인과 검진의 필요성을 증가시키고 있습니다. 또한, 폐경기는 심혈관 질환과 요실금 등 특정 질환의 발병 위험을 증가시킬 수 있기 때문에 50세 이상 여성 인구가 크게 증가하면서 시장 성장에 기여하고 있습니다. 이와 더불어, 여러 연구에 따르면 여성은 호르몬 변화 시 우울증이나 불안증과 같은 정신 질환을 경험할 가능성이 높다는 결론을 내리고 있습니다. 이는 여성의 정신 건강을 개선하기 위해 많은 국가의 보건 기관에서 시행하고 있는 여러 노력과 함께 전 세계 시장 성장을 가속하고 있습니다.
본 보고서에서 다룬 주요 질문들
- 2023년 세계 부인과 건강검진 시장 규모는?
- 2024-2032년 세계 부인과 건강검진 시장의 성장률은?
- 세계 부인과 건강검진 시장을 이끄는 주요 요인은?
- 코로나19가 세계 부인과 건강검진 시장에 미친 영향은?
- 부인과 건강검진 세계 시장 유형별 분류는?
- 부인과 건강검진 세계 시장 용도별 분류는?
- 부인과 건강검진 세계 시장의 최종 사용자별 분류는?
- 부인과 건강검진 세계 시장의 주요 지역은?
- 세계 부인과 건강검진 시장의 주요 진출 기업은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 부인과 건강검진 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 분석 : 유형별
- 진단 기기
- 시장 동향
- 주요 부문
- 생검 기기
- 영상 진단 및 모니터링 기기
- 부속품 및 소모품
- 시장 예측
- 진단 테스트
- 시장 동향
- 주요 부문
- 유방암 검사
- PAP Smear 검사 및 HPV 검사
- 임신 검사 및 배란 검사
- 기타
- 시장 예측
제7장 시장 분석 : 용도별
- 유방암
- 감염증 검사
- 골다공증 검사
- 임신 및 불임 검사
- 성감염증 검사
- 기타
제8장 시장 분석 : 최종사용자별
제9장 시장 분석 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter의 Five Forces 분석
- 개요
- 바이어의 교섭력
- 공급 기업의 교섭력
- 경쟁 정도
- 신규 진출업체의 위협
- 대체품의 위협
제13장 가격 분석
제14장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 개요
- Abbott Laboratories
- Becton Dickinson and Company
- bioMerieux SA
- Cardinal Health Inc.
- Cook Group Incorporated
- F. Hoffmann-La Roche AG
- General Electric Company
- Hologic Inc.
- Koninklijke Philips N.V.
- Perkinelmer Inc.
- Quest Diagnostics Inc.
- Siemens AG
- Thermo Fisher Scientific Inc.
LSH
The global women's health diagnostics market size reached US$ 29.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 52.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032.
Women's health diagnostics help diagnose various biological and psychosocial conditions of female patients. They assist in addressing sexual and vaginal issues and pregnancy complications and managing threatening diseases, such as osteoporosis, menopause, and certain cancers like breast and cervical. They rely on a series of advanced laboratory tests, tools, and procedures, which include biopsy, ultrasound, chemotherapy, and magnetic resonance imaging (MRI). Several healthcare diagnostics centers are currently offering an expansive range of laboratory testing solutions to enhance the diagnosis and management of rare diseases and conditions that affect women.
Women's Health Diagnostics Market Trends:
The rising prevalence of health issues that impact the overall well-being of women represents one of the major factors influencing the market positively. Moreover, the growing health consciousness, along with the increasing awareness about the benefits of early diagnosis, is catalyzing the demand for point-of-care (POC) women's health diagnostics across the globe. Apart from this, the rising rate of infertility on account of stressful lifestyles and the growing consumption of alcohol and drugs is driving the need for women's health diagnostics to address pregnancy complications and ensure a healthier life. Furthermore, as menopause can increase the risk of developing certain medical conditions, including cardiovascular diseases and urinary incontinence, a significant rise in the female population which is over 50 years is contributing to the market growth. Besides this, several research studies have concluded that women are more likely to experience psychiatric disorders, such as depression and anxiety, during hormonal changes. This, in confluence with several initiatives undertaken by health agencies of numerous countries to improve mental health of women, is propelling the market growth across the globe.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global women's health diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application, and end user.
Breakup by Type:
Diagnostic Devices
Biopsy Device
Imaging and Monitoring Devices
Accessories and Consumables
Diagnostic Tests
Breast Cancer Testing
PAP Smear and HPV Test
Pregnancy Testing and Ovulation Testing
Others
Breakup by Application:
Breast Cancer
Infectious Disease Testing
Osteoporosis Testing
Pregnancy and Fertility Testing
Sexually Transmitted Disease Testing
Others
Breakup by End User:
Hospital and Diagnostics Centers
Home Care
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
- 1. What was the size of the global women's health diagnostics market in 2023?
- 2. What is the expected growth rate of the global women's health diagnostics market during 2024-2032?
- 3. What are the key factors driving the global women's health diagnostics market?
- 4. What has been the impact of COVID-19 on the global women's health diagnostics market?
- 5. What is the breakup of the global women's health diagnostics market based on the type?
- 6. What is the breakup of the global women's health diagnostics market based on the application?
- 7. What is the breakup of the global women's health diagnostics market based on the end user?
- 8. What are the key regions in the global women's health diagnostics market?
- 9. Who are the key players/companies in the global women's health diagnostics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Women's Health Diagnostics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Diagnostic Devices
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Biopsy Device
- 6.1.2.2 Imaging and Monitoring Devices
- 6.1.2.3 Accessories and Consumables
- 6.1.3 Market Forecast
- 6.2 Diagnostic Tests
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Breast Cancer Testing
- 6.2.2.2 PAP Smear and HPV Test
- 6.2.2.3 Pregnancy Testing and Ovulation Testing
- 6.2.2.4 Others
- 6.2.3 Market Forecast
7 Market Breakup by Application
- 7.1 Breast Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Infectious Disease Testing
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Osteoporosis Testing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Pregnancy and Fertility Testing
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Sexually Transmitted Disease Testing
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospital and Diagnostics Centers
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Home Care
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Becton Dickinson and Company
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 bioMerieux SA
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Cardinal Health Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Cook Group Incorporated
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 F. Hoffmann-La Roche AG
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.7 General Electric Company
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Hologic Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Koninklijke Philips N.V.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Perkinelmer Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Quest Diagnostics Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Siemens AG
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.13 Thermo Fisher Scientific Inc.
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.13.3 Financials
- 14.3.13.4 SWOT Analysis
